HPV Vaccine May Join National Vaccination Schedule by 2026
The Russian government may include the HPV vaccine in the national vaccination schedule by the end of 2026, following a statement by State Duma Health Committee Chairman Sergey Leontiev, who expressed confidence in parliamentary support for the move.
Consensus
- The HPV vaccine may be included in the national vaccination schedule by the end of 1926.
- Sergey Leontiev, Chairman of the State Duma Health Committee, stated that the government may introduce a budgetary legislative initiative on this matter in autumn.
- Leontiev expressed confidence that deputies of the State Duma will support the decision.
- HPV is a group of more than 150 virus types, with types 16 and 18 being highly oncogenic and linked to cervical cancer.
- HPV infection is a major cause of cervical cancer, responsible for about 70% of cases worldwide.
Points of divergence
- The State Duma Health Committee Chairman mentioned that the vaccine could be included in the national calendar in 2026. — vm
- The frequency of infection with oncogenic HPV types in Russia ranges from 13% to 40%. — m24
- Approximately 99% of cervical cancer cases worldwide are due to HPV infection, affecting about 600,000 women annually. — m24
Coverage (2 sources)
- The HPV vaccine may be included in the national vaccination schedule by the end of 2026 — Вечерняя Москва
- HPV vaccine may be included in national vaccination schedule by end of 2026 — Москва 24
Key entities
More on Sergey Leonov
- Mobile Pharmacies Launch in Rural Russia Sept 1
- Russia Bans Tobacco Sales on Transport Stops
- Russia has shortened the mandatory medical examination period for…